In a cohort of 60 surgically removed BLCA samples, RAC3 was found to be overexpressed (detectable at >1%) in 62% of the cases, with 37 of 60 samples testing positive, and it was under expressed (detectable at <1%) in 38% of the cases, with 23 of 60 samples testing negative (Figure 1C). The gene discussed is RAC3; the disease is bladder transitional cell carcinoma.